Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
What is Baird Medical Investment Holdings PB Ratio?
Baird Medical Investment HoldingsBDMD -2.86%17 PB Ratio is 1.04 as of Jul. 26, 2026, which is 41% below its 10-year median of 1.75. GuruFocus rates BDMD with a GF Score™ of 17/100. The stock has 7 warning signs investors should review. Among 788 Medical Devices & Instruments companies, Baird Medical Investment Holdings ranks better than 77.66% on this metric.
BDMD'
s PB Ratio Range Over the Past 10 Years
Min: 0.69 Med: 1.75 Max: 5.71
Current: 1.04
During the past 5 years, Baird Medical Investment Holdings's highest PB Ratio was 5.71. The lowest was 0.69. And the median was 1.75.
BDMD's PB Ratio is ranked better than 77.66% of 788
companies
in the Medical Devices & Instruments industry
Industry Median: 2.005
vs BDMD: 1.04
During the past 12 months, Baird Medical Investment Holdings's average Book Value Per Share Growth Rate was -34.30% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was 11.70% per year.
During the past 5 years, the highest 3-Year average Book Value Per Share Growth Rate of Baird Medical Investment Holdings was 52.90% per year. The lowest was 11.70% per year. And the median was 32.30% per year.
Back to Basics: PB Ratio
Baird Medical Investment Holdings (NAS:BDMD) PB Ratio Explanation
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
Baird Medical Investment Holdings PB Ratio Related Terms
Baird Medical Investment Holdings PB Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Baird Medical Investment Holdings PB Ratio Chart
Baird Medical Investment Holdings Annual Data
Trend
Dec21
Dec22
Dec23
Dec24
Dec25
PB Ratio
0.00
0.00
0.00
4.90
1.33
Baird Medical Investment Holdings Semi-Annual Data
For the Medical Devices subindustry, Baird Medical Investment Holdings's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Baird Medical Investment Holdings PB Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Baird Medical Investment Holdings's PB Ratio distribution charts can be found below:
* The bar in red indicates where Baird Medical Investment Holdings's PB Ratio falls into.
Baird Medical Investment Holdings PB Ratio Calculation
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
Baird Medical Investment Holdings (BDMD) has a PB Ratio of 1.04 as of Jul. 26, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Baird Medical Investment Holdings and its competitors. This is 41% below median its historical median of 1.75. Over the past decade, Baird Medical Investment Holdings' PB Ratio has ranged from 0.69 to 5.71. According to the industry distribution chart, Baird Medical Investment Holdings ranks #176 out of 788 companies in the Medical Devices & Instruments industry, placing it in the top 22.3%.
Is Baird Medical Investment Holdings' PB Ratio too high?
Baird Medical Investment Holdings' current PB Ratio of 1.04 is 41% below median its 10-year median of 1.75. Over the past 10 years, this metric has ranged from a low of 0.69 to a high of 5.71. The Medical Devices & Instruments industry median PB Ratio is 2.01. Baird Medical Investment Holdings' value of 1.04 is 48.1% below this industry median. Based on the distribution chart, Baird Medical Investment Holdings ranks #176 out of 788 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Baird Medical Investment Holdings has a GF Score™ of 17/100, reflecting its overall financial health beyond just this single metric.
How does Baird Medical Investment Holdings' PB Ratio compare to TELA and NSPR?
According to the Medical Devices & Instruments industry distribution chart, Baird Medical Investment Holdings ranks #176 out of 788 companies for PB Ratio. This places Baird Medical Investment Holdings in the top 22% of its industry — outperforming the majority of peers. The industry median PB Ratio is 2.01. Baird Medical Investment Holdings' value of 1.04 is 48.1% below this benchmark. Historically, Baird Medical Investment Holdings' own PB Ratio has ranged from 0.69 to 5.71 over the past decade. While the company's 10-year median is 1.75 vs. the industry median of 2.01, Baird Medical Investment Holdings has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Medical Devices & Instruments company?
The median PB Ratio among Medical Devices & Instruments companies is 2.01, based on 788 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Baird Medical Investment Holdings's current PB Ratio of 1.04 is 48.1% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Baird Medical Investment Holdings and its competitors. For the Medical Devices & Instruments industry, the median PB Ratio is 2.01 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Baird Medical Investment Holdings's current PB Ratio is 1.04, which is 41% below median its own 10-year median of 1.75. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Baird Medical Investment Holdings stock overvalued right now?
Baird Medical Investment Holdings (BDMD) has a current PB Ratio of 1.04. The current PB Ratio is 1.04, which is 41% below median its 10-year median of 1.75 and 48.1% below the Medical Devices & Instruments industry median of 2.01. Baird Medical Investment Holdings' overall GF Score™ is 17/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For Baird Medical Investment Holdings (BDMD), the current PB Ratio is 1.04 as of Jul. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Baird Medical Investment Holdings Business Description
Baird Medical Investment Holdings Ltd is a specialized healthcare innovator dedicated exclusively to thyroid-related diseases and a microwave ablation (MWA) medical device manufacturer and provider in China. The company combines clinical expertise with technologies to develop non-invasive treatment solutions. Its proprietary MWA medical devices are used for the treatment of benign and malignant tumors, including thyroid nodules, liver cancer, lung cancer, and breast lumps. Its core activities include the development and commercialization of thyroid microwave ablation systems and an active R&D pipeline of AI-integrated robotic systems, integrating hardware, software, and system-based solutions.
17GF Score
Get the complete analysis for BDMD
PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BDMD has been successfully added to your 
